Because we seek overlap between methods and resources, and used FG cohorts that were depleted of other cancers (Figure 6, Table 3), some classical predisposition genes that play a central role in pan-cancer predisposition were therefore excluded (e.g., TP53, PTEN) [71]. The gene discussed is TP53; the disease is cancer.